%0 Journal Article %A Hayashi, Tomoyuki %A Yamashita, Taro %A Terashima, Takeshi %A Suda, Tsuyoshi %A Okada, Hikari %A Asahina, Yoshiro %A Hayashi, Takehiro %A Hara, Yasumasa %A Nio, Kouki %A Sunagozaka, Hajime %A Takatori, Hajime %A Arai, Kuniaki %A Sakai, Yoshio %A Yamashita, Tatsuya %A Mizukoshi, Eishiro %A Honda, Masao %A Kaneko, Shuichi %D 2017 %T Additional file 2: Figure S2. of Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study %U https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Figure_S2_of_Serum_cytokine_profiles_predict_survival_benefits_in_patients_with_advanced_hepatocellular_carcinoma_treated_with_sorafenib_a_retrospective_cohort_study/5722183 %R 10.6084/m9.figshare.5722183.v1 %2 https://ndownloader.figshare.com/files/10056847 %K Hepatocellular carcinoma %K Sorafenib %K Hepatic arterial infusion chemotherapy %K Cytokine %K Chemokine %K Growth factor %X Comparison of serum IL-5, CXCL9, and VGEF-A levels between long survivors and non-long survivors in the 2 cohorts. (PDF 117 kb) %I figshare